Results 221 to 230 of about 31,245 (262)
Some of the next articles are maybe not open access.
Health Economics in the Canadian Pharmaceutical Industry
PharmacoEconomics, 1999To assess the goals, strategic focus, structure, capabilities, activities and effectiveness of health economics (HE) departments in the Canadian pharmaceutical industry, to examine how these have evolved, and the implications of HE in the future of the pharmaceutical industry.A mixture of telephone and face-to-face interviews with members of the HE ...
L, Assiff +4 more
openaire +2 more sources
Pharmaceutical Economics and Policy
2018Pharmaceuticals play a critical role in the raging debate over how best to advance and improve healthcare in the United States and the rest of the world. Using the analytical tools of economics, this book explores the conflicting priorities and aims of the biopharmaceutical industry. It starts out by describing the supply side of pharmaceuticals in all
Stuart O. Schweitzer, Z. John Lu
openaire +1 more source
Economics, Pharmaceuticals, and Pharmacoeconomics
Medical Decision Making, 1998M, Johannesson, B J, O'Brien
openaire +2 more sources
Issues in Mandatory Economic Assessment of Pharmaceuticals
Health Affairs, 1992Australia is expanding assessment of pharmaceuticals by requiring economic evaluation before drugs are marketed. While such assessment is voluntary at first for pharmaceutical firms, it becomes mandatory by January 1993. Michael Drummond has provided an excellent analysis of this new policy initiative, describing in detail the means, methods, and ...
openaire +2 more sources
Economic evaluation of pharmaceuticals
2019Around the world, health policy decision makers and payers are compelled to ensure delivery of quality health care under ever-tighter budgetary constraints and increasing demand. This is due to many factors, including ageing populations, expensive health technologies, and financial uncertainty.
Ademi, Zanfina, Liew, Danny
openaire +1 more source
Economic impact of poor compliance with pharmaceuticals
Expert Review of Pharmacoeconomics & Outcomes Research, 2002Poor compliance with prescribed drug regimens is a widespread phenomenon which results in decreased efficacy and is often associated with increased medical expenditures due to treatment failure and/or adverse events. This review examines the issues relating to the measurement of compliance and the clinical and economic consequences of noncompliant drug
openaire +2 more sources
Economic evaluation of pharmaceuticals
1995Bibliography: p. 23-27.
O'Brien, Bernie J. +1 more
openaire +1 more source
Pharmaceutical Economics begins with an investigation of the structure of the industry and its three main components: the research firms which produce innovative products; the generic drug industry and its expanding role; and the biotech industry, which is regarded as the future for pharmaceuticals.
openaire +1 more source
openaire +1 more source